Lakshmi V M, Hsu F F, Davis B B, Zenser T V
VA Medical Center, Division of Geriatric Medicine and Department of Biochemistry, St. Louis University School of Medicine, St. Louis, Missouri 63125-4199, USA.
Chem Res Toxicol. 2000 Aug;13(8):785-92. doi: 10.1021/tx0000320.
N'-(3'-Monophosphodeoxyguanosin-8-yl)-N-acetylbenzidine (dGp-ABZ) is the major adduct in exfoliated urothelial cells and in peripheral white blood cells of workers exposed to benzidine. This study was designed to assess the metabolic pathways leading to dGp-ABZ formation in human peripheral white blood cells. [(3)H]-N-Acetylbenzidine (ABZ) transformation was assessed using myeloperoxidase (MPO), hypochlorous acid (HOCl), and human peripheral white blood cells in the absence and presence of DNA or dGp. MPO metabolism required H(2)O(2), but not NaCl. While transformation by HOCl was completely inhibited by 10 mM taurine, the level of metabolism of ABZ by MPO was only reduced 56%. Transformation by either MPO or HOCl was inhibited by 100 mM DMPO, 1 mM glutathione, and 1 mM ascorbic acid. Glutathione formed a new product with MPO, but not with HOCl. Previously identified oxidation products of ABZ, N'-hydroxy-N-acetylbenzidine or 4'-nitro-4-acetylaminobiphenyl, were not detected. With DNA or dGp present, a new product was observed that corresponded to synthetic dGp-ABZ in its HPLC elution profile, in nuclease P(1) hydrolysis to dG-ABZ, and in (32)P-postlabeling analysis. The HOCl-derived adduct was identified by electrospray ionization mass spectrometry, with collision-activated dissociation, as dGp-ABZ. Metabolism of [(3)H]ABZ by peripheral blood cells was stimulated about 3-fold with 30 ng/mL beta-phorbol 12-myristate 13-acetate (PMA). Using (32)P-postlabeling, dGp-ABZ was detected only in the presence of PMA and its level was increased more than 300-fold if either 0.7 mg/mL DNA or dGp was present. Indomethacin (0.1 mM) did not alter adduct formation. With dGp, dGp-ABZ formation could be detected with as little as 0.12 x 10(6) neutrophils. Using specific chromatographic and enzymatic techniques, neutrophil-derived dGp-ABZ was identical to the synthetic standard. Thus, these results are consistent with human polymorphonuclear neutrophils forming dGp-ABZ by a peroxidatic mechanism involving MPO.
N'-(3'-单磷酸脱氧鸟苷-8-基)-N-乙酰联苯胺(dGp-ABZ)是接触联苯胺工人脱落的尿路上皮细胞和外周血白细胞中的主要加合物。本研究旨在评估导致人外周血白细胞中dGp-ABZ形成的代谢途径。使用髓过氧化物酶(MPO)、次氯酸(HOCl)以及在有无DNA或dGp存在的情况下的人外周血白细胞来评估[(3)H]-N-乙酰联苯胺(ABZ)的转化。MPO代谢需要H(2)O(2),但不需要NaCl。虽然HOCl介导的转化被10 mM牛磺酸完全抑制,但MPO介导的ABZ代谢水平仅降低了56%。MPO或HOCl介导的转化被100 mM DMPO、1 mM谷胱甘肽和1 mM抗坏血酸抑制。谷胱甘肽与MPO形成了一种新产物,但与HOCl未形成新产物。未检测到先前鉴定的ABZ氧化产物N'-羟基-N-乙酰联苯胺或4'-硝基-4-乙酰氨基联苯。在有DNA或dGp存在的情况下,观察到一种新产物,其在高效液相色谱洗脱图谱、核酸酶P(1)水解为dG-ABZ以及(32)P后标记分析中与合成的dGp-ABZ一致。通过电喷雾电离质谱结合碰撞活化解离鉴定出HOCl衍生的加合物为dGp-ABZ。30 ng/mL佛波酯12-肉豆蔻酸酯13-乙酸酯(PMA)可使外周血细胞对[(3)H]ABZ的代谢刺激约3倍。使用(32)P后标记法,仅在有PMA存在时检测到dGp-ABZ,并且如果存在0.7 mg/mL DNA或dGp,其水平增加超过300倍。吲哚美辛(0.1 mM)不改变加合物的形成。对于dGp,低至0.12×10(6)个中性粒细胞就能检测到dGp-ABZ的形成。使用特定的色谱和酶学技术,中性粒细胞衍生的dGp-ABZ与合成标准品相同。因此,这些结果与人多形核中性粒细胞通过涉及MPO的过氧化物机制形成dGp-ABZ一致。